Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adultsAmy S. Paller, Adelaide A. Hebert, Mark Boguniewicz et al.|Journal of the American Academy of Dermatology|2016Cited by 564
Consensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi ProcessPaige Kingston, April W. Armstrong, Leon Kircik et al.|Journal of Drugs in Dermatology|2024Cited by 0